NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene.

Abstract : NFAT1 and NFAT5 act as pro-invasive and pro-migratory transcription factors in breast carcinoma, contributing to the formation of metastases. We report that NFAT3 is specifically expressed in estrogen receptor alpha positive (ERA+) breast cancer cells. We show that NFAT3 inhibits by itself the invasion capacity of ERA+ breast cancer cells and needs to cooperate with ERA to inhibit their migration. Conversely, NFAT3 downregulation results in actin reorganization associated with increased migration and invasion capabilities. NFAT3 signaling reduces migration through inhibition of Lipocalin 2 (LCN2) gene expression. Collectively, our study unravels an earlier unknown NFAT3/LCN2 axis that critically controls motility in breast cancer.
Type de document :
Article dans une revue
Oncogene, Nature Publishing Group, 2010, 29 (15), pp.2292-301. 〈10.1038/onc.2009.499〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00541837
Contributeur : Sebastien Jauliac <>
Soumis le : mercredi 1 décembre 2010 - 12:15:35
Dernière modification le : mercredi 12 octobre 2016 - 01:00:54

Lien texte intégral

Identifiants

Collections

Citation

Marjorie Fougère, Benoît Gaudineau, Jérome Barbier, Frédéric Guaddachi, Jean-Paul Feugeas, et al.. NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene.. Oncogene, Nature Publishing Group, 2010, 29 (15), pp.2292-301. 〈10.1038/onc.2009.499〉. 〈inserm-00541837〉

Partager

Métriques

Consultations de la notice

205